ICGex

Eleonora Timperi et al.
Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer
Cancer Research 2022, vol. 82, issue 18
doi: 10.1158/0008-5472.can-22-1427

Alina Chakraborty et al.
Compartment-specific and ELAVL1-coordinated regulation of intronic polyadenylation isoforms by doxorubicin
Genome Research 2022, vol. 32, issue 7
doi: 10.1101/gr.276192.121

Riccardo Gamba et al.
Enrichment of centromeric DNA from human cells
PLOS Genetics 2022, vol. 18, issue 7
doi: 10.1371/journal.pgen.1010306

Yujiao Zhang et al.
Genetic inhibition of CARD9 accelerates the development of experimental atherosclerosis through CD36 dependent-defective autophagy
2022
doi: 10.21203/rs.3.rs-1834549/v1

Mathilde Saint-Ghislain et al.
MBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients
European Journal of Cancer 2022, vol. 173
doi: 10.1016/j.ejca.2022.06.033

M

Leticia Laura Niborski et al.
CD8+T cell responsiveness to anti-PD-1 is epigenetically regulated by Suv39h1 in melanomas
Nature Communications 2022, vol. 13, issue 1
doi: 10.1038/s41467-022-31504-z

Jessica Sriha et al.
BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells
Cancers 2022, vol. 14, issue 11
doi: 10.3390/cancers14112755

Maxime Wack et al.
viroCapt: A Bioinformatics Pipeline for Identifying Viral Insertion in Human Host Genome
Studies in Health Technology and Informatics 2022
doi: 10.3233/shti220602

M

Laia Richart et al.
XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivation
Cell 2022, vol. 185, issue 12
doi: 10.1016/j.cell.2022.04.034

M

Julien Vibert et al.
Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions
Molecular Cell 2022, vol. 82, issue 13
doi: 10.1016/j.molcel.2022.04.019